Industry Reports

Microbiome comapany developing customized phage therapies , BiomX Ltd. declared that it has sought sub-license from JSR Corporation a set of bacterial targets for the development and…
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...

Agilent Technologies ventured into a partnership with Science Exchange to met out Agilent-enabled services to the research community worldwide. Carolina Livi, Ph.D., academic segment…
Read More...

Sanofi and Ablynx engaged in the discovery and development of Nanobodies forayed into an agreement under which Sanofi will extend acquisition of all of the outstanding ordinary shares,…
Read More...

Dragonfly Therapeutics welcomes on board Dr. Jean-Marie Cuillerot, MD as its Chief Medical Officer. Dr. Cuillerot set to spearhead clinical development of Dragonfly's natural Killer…
Read More...

Harris Healthcare asserts that Emerald Health Information Systems will transition from MediSolution, Harris Healthcare's sister company under the Harris umbrella, to Harris Healthcare…
Read More...

Supplier of quality compounding products, supplies and equipment, Letco Medical along with ARL Bio Pharma collaborate to roll out their joint Quality Savings Program. The program…
Read More...

Global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, QT Vascular successfully…
Read More...

Wuxi Biologics and Aravive Biologics collaborate to extend their biologics manufacturing collaboration, based on the rapid success achieved in the process development, scale-up and cGMP…
Read More...

TFS International and Arclon Biotech decided to continue their partnership with TFS advancing their Alzheimer's disease vaccine ABvac40 into phase II. AD is a progressive disease…
Read More...

Intelligent Retinal Imaging Systems (IRIS), asserted the appointment of Chris Belmont as interim CEO effective immediately.  IRIS also named Steve Martin as Chief Commercial Officer and…
Read More...

Sterling Pharma Solutions witnessed growth in the Japanese market owing to its technical capabilities and innovation strategy. Sterling's technology and innovation strategy, which has…
Read More...

Avista Pharma Solutions completed acquisition of  Solid Form Solutions located in Edinburgh, Scotland. Solid Form Solutions provider of solid state chemistry and crystallization…
Read More...

Leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, REGENXBIO, forays…
Read More...

CASI  Pharmaceuticals, committed to ushering in quality pharmaceutical products to the Chinese and U.S markets proclaimed that it has obtained a portfolio of 25 U.S FDA- approved…
Read More...

Behavioral health and addiction recovery center in Houston, Texas, Sacred Oak Medical Center rescinds agreement with RedShift Healthcare Management, LLC with effect from immediate…
Read More...

Novartis proclaimed a licensing agreement with Spark Therapeutics encompassing development, registration and commercialization rights to voretigene neparvovec in markets outside the US.…
Read More...

With a view to addressing a $1.8 billion market globally, and a European market estimated to exceed $500 million, TechCare Corporation a technology company with a revolutionary delivery…
Read More...

Leading provider of clinical trial support services, Paragon International affirmed new name "Paragon Global CRS" The name symbolizes the variety of services currently being offered by…
Read More...